January 27, 2025
Global Market Comments January 27, 2025 Fiat Lux Featured Trade: (MARKET OUTLOOK FOR THE WEEK AHEAD, or THE TRADE WAR BEGINS), (SPY), (TLT), (TSLA), (NFLX)
Entries by april@madhedgefundtrader.com
The Market Outlook for the Week Ahead, or The Trade War begins
The punitive 25% tariff against Columbia for refusing to take back their own immigrants clearly signals how international relations will be conducted going forward. Never mind that it was rolled back 25 hours later. The intentions are clear. Notice that it is America’s biggest exporters, the Magnificent Seven, that are getting absolutely slaughtered this morning.
January 24, 2025
Mad Hedge Technology Letter January 24, 2025 Fiat Lux Featured Trade: (HUMANOIDS TO THE RESCUE OR NOT) (TSLA)
Humanoids To The Rescue Or Not
Dr. Doom Nouriel Roubini needs to lay off the fear porn – I’m not taking the bait this time. Sorry Roubs! Roubini is sounding the alarm bells on humanoid robots, but I think it is more of a case of fear-mongering than anything else. After all, like most economists, Roubini isn’t a trader, he is
January 24, 2025
(PRESIDENT TRUMP IS PRIORITIZING AI) January 24, 2025 Hello everyone President Trump is prioritizing the push forward of AI. Which companies are likely to benefit? Think of (ORCL) Oracle, (MSFT) Microsoft, and (ANET) Arista Networks Earlier this week, a $500 billion joint venture was announced between OpenAI Oracle, and Softbank, which
January 24, 2025
Global Market Comments January 24, 2025 Fiat Lux Featured Trade: (SOME SAGE ADVICE ON ASSET ALLOCATION)
Some Sage Advice About Asset Allocation
Asset allocation is the one question that I get every day, which I absolutely cannot answer. The reason is simple: no two investors are alike. The answer varies whether you are young or old, have $1,000 in the bank or $1 billion, are a sophisticated investor or an average Joe, are in the top or
Trade Alert - (DELL) January 23, 2025 - BUY
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
January 23, 2025
Mad Hedge Biotech and Healthcare Letter January 23, 2025 Fiat Lux Featured Trade: (THE HARD TRUTH ABOUT THIS BIOTECH'S PIPELINE THAT WALL STREET DOESN'T GET) (MRK), (AMGN), (AAPL)
The Hard Truth About This Biotech's Pipeline That Wall Street Doesn't Get
Earlier this month, while reviewing my biotech holdings during a layover at Chicago O'Hare, I got an interesting call from a long-time reader. He was panicking about Merck (MRK) after seeing it trading near its 52-week lows, convinced the pharmaceutical giant was headed for trouble. "Have you seen what Medicare negotiations did to Januvia?" he